Rising prominence of India and China as pharmaceutical exporters to Algeria to challenge multinational presence in the country. Excessive amount of red tape to continue hampering market access for new medicines in particular. ...Excessive amount of red tape to continue hampering market access for new medicines in particular. A failure to revise pricing regulations and import restrictions damaging chances of World Trade Organisation accession and deterring multinational investment. Direct multinational involvement discouraged by continued threat of terrorism. ...Government drive to increase and improve local production of medicines to further discourage imports. In recent years the government denounced certain multinational drugmakers to be overpricing products, which suggests a cautious view by public authorities to costly products.
...� Business Monitor International Ltd Page - Pharmaceutical SWOT Analysis - Continued Healthcare modernisation financed by oil and gas revenue and a relatively solid fiscal position. Rising number of medical personnel, as the government invests in medical training programmes. ...Rising number of medical personnel, as the government invests in medical training programmes. Improvement of smart healthcare cards to reduce administrative wastage, with the savings potential invested elsewhere in the healthcare system. Government efforts to stimulate local manufacturing supporting export growth. ...Government efforts to stimulate local manufacturing supporting export growth. Under the terms of a memorandum of understanding, US association PhRMA and the Algerian government are part of a framework for collaboration towards Algeria Vision ---- , aimed at boosting Algeria as a regional hub in advanced pharmaceutical and biotechnology manufacturing.
...BMI View: Algeria s large and growing healthcare and pharmaceutical market will continue to drive interest from multinational drugmakers over the forecast period. Meanwhile, Algeria s pharmaceutical exports will continue to expand as the country gradually strengthens its position as a key drug manufacturing hub in the Middle East and Africa region. ...